AIM
GTHX

Assured Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Assured Investment Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,818
Closed -$429K – 918
2019
Q1 		$429K Buy
+25,818
New +$490K ﹤0.01% 621
2018
Q4 		– Sell
-908
Closed -$47K – 1358
2018
Q3 		$47K Buy
+908
New +$49.5K ﹤0.01% 1096

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Assured Investment Management's GTHX Position: Q2 2019 in Review

Assured Investment Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2019, closing a stake of 25,818 shares — an estimated $429K sold.

Assured Investment Management first reported a position in GTHX in Q3 2018 and held it in 2 quarters. The position peaked at $429K in Q1 2019. 94 funds tracked by Wall St. Rank hold GTHX as of Q2 2019.

  • Assured Investment Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 25,818 G1 Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $429K.
  • Assured Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
  • Assured Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $429K in Q1 2019.
  • 94 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.